AZITHROMYCIN FOR INJECTION, USP
HOSPIRA HEALTHCARE CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is AZITHROMYCIN FOR INJECTION, USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that AZITHROMYCIN FOR INJECTION, USP 500MG has been permanently discontinued (last updated March 28, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is AZITHROMYCIN FOR INJECTION, USP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AZITHROMYCIN FOR INJECTION, USP
HOSPIRA HEALTHCARE ULC
Other Products
ZITHROMAX CAP 250MG
PFIZER CANADA ULC
ZITHROMAX 600MG
PFIZER CANADA ULC
PMS-AZITHROMYCIN
PHARMASCIENCE INC
AZITHROMYCIN
PHARMASCIENCE INC
SANDOZ AZITHROMYCIN
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02334844
Strength
500MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Active Ingredient
AZITHROMYCIN
Tier
Unrated
Last Updated
2019-03-28
Reason for Shortage
Business reasons
Past Reports for This Drug
AZITHROMYCIN FOR INJECTION, USP has 2 shortage/discontinuation reports on file — this is one of them.